By an alternative transcript of the ENO1 gene but post-translationally…

By an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover. FEBS J. 2010;277(20):4308?1. Subramanian A, Miller DM. Structural analysis of alpha-enolase mapping the functional domains involved in down-regulation of the c-Myc protooncogene. J Biol Chem. 2000;275(8):5958?5. Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics. 2004;84(6):1014?0. Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, et al. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res. 2006;12(19):5746?4. He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci. 2007;98(8):1234?0. Chang YS, Wu W, Walsh G, Hong WK, Mao L. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clin PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/15501003 Cancer Res. 2003;9(10 Pt 1):3641?. Zhou XZYHN. -Enolase (ENO1) inhibits epithelial-mesenchymal transition in the A549 cell line by suppressing ERK1/2 phosphorylation. Zhongguo Fei Ai Za Zhi. 2013;05:221?. Song Y, Luo Q, Long H, Hu Z, Que T, Zhang X, et al. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol Cancer. 2014;13:65. Zhen Y, Ye Y, Yu X, Mai C, Zhou Y, Chen Y, et al. Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma. PLoS One. 2013;8(6):e64976. Dong X, Yu LG, Sun R, Cheng YN, Cao H, Yang KM, et al. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells. J Cell Biochem. 2013;114(1):174?2. Beckner ME, Fellows-Mayle W, Zhang Z, Agostino NR, Kant JA, Day BW, et al. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. Int J Cancer. 2010;126(10):2282?5. Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, et al. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer. 2010;46(9):1712?3. Cappello P, Rolla S, Chiarle R, Principe M, Cavallo F, Perconti G, et Nelfinavir (Mesylate) al. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology. 2013;144(5):1098?06. Yu L, Shi J, Cheng S, Zhu Y, Zhao X, Yang K, et al. Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells. Mol Endocrinol. 2012;26(9):1521?0. Ho JA, Chang HC, Shih NY, Wu LC, Chang YF, Chen CC, et al. Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticlebased electrochemical immunosensor. Anal Chem. 2010;82(14):5944?0. Chu PY, Hsu NC, Liao AT, Shih NY, Hou MF, Liu CH. Overexpression of alpha-enolase correlates with poor survival in canine mammary carcinoma. BMC Vet Res. 2011;7:62. Trojanowicz B, Sekulla C, Lorenz K, Kohrle J, Finke R, Dralle H, et al. Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma. Mol Cell Endocrinol. 2010;325(1?):110?. Yonglitthipagon P, Pairojkul C, Bhudhisawasdi V, Mulvenna J, Loukas A, Sripa B. Proteomics-based identification of alpha-enolase as a potential prognostic marker in cholangiocarcinoma. Clin Biochem. 2012;45(10?1):827?4.28. Leal MF, Chung J, Calcagno DQ,.